Illumina

R&D

Whole-genome sequencing in the UK and Europe, with Mark Robi...

Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.

News

JPM: Illumina launches 'unprecedented' disease biology atlas

Illumina says its new Billion Cell Atlas can be used to identify and validate drug targets and train AI models used in drug discovery.

News

Hands uniting in the centre of a circle of children

Irish study promises to revolutionise childhood cancer care

A five-year genomics study that aims to transform the care of children with cancer and improve treatment success has launched in Ireland.

News

Truveta's co-founder and chief executive, Terry Myerson

Regeneron, Illumina join $320m Truveta investment

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project.

Oncology

ESMO 2024 Dr Magda Meissner interview with Nicole Raleigh

ESMO 2024 – Magda Meissner

In our penultimate video from ESMO 2024, pharmaphorum spoke with Dr Magda Meissner, consultant medical oncologist at the Velindre Cancer Centre and project lead for QuicDNA, about how a sim

Oncology

Sven Schaffer and Nicole Raleigh interview at ESMO

ESMO 2024 - Sven Schaffer

The European Society for Medical Oncology (ESMO) 2024 meeting was a well-attended affair at the sprawling Fira Gran Via centre in Barcelona.

Whole-genome sequencing in the UK and Europe, with Mark Robi...

JPM: Illumina launches 'unprecedented' disease biology atlas

Irish study promises to revolutionise childhood cancer care

Regeneron, Illumina join $320m Truveta investment

ESMO 2024 – Magda Meissner

ESMO 2024 - Sven Schaffer

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

Illumina

Editor's Picks